NEFL and amyotrophic lateral sclerosis: However, neuroprotection of spinal motor neurons by FP802 was accompanied by a reduction of serum levels of neurofilament light (NfL) chain, a biomarker used in ALS patients to monitor disease progression (Figure 2K).35